Brain Cancer
180
35
44
91
Key Insights
Highlights
Success Rate
78% trial completion
Published Results
34 trials with published results (19%)
Research Maturity
91 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.4%
26 terminated out of 180 trials
77.8%
-8.8% vs benchmark
6%
10 trials in Phase 3/4
37%
34 of 91 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 91 completed trials
Clinical Trials (180)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
Natural History of and Specimen Banking for People With Tumors of the Central Nervous System
Immunogene-modified T (IgT) Cells Against Glioblastoma Multiforme
Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor Biomarker
Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.
Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma
Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-Being
VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations
Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GBM
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma